Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saw palmetto for Benign Prostatic Hyperplasia (CAMUS)
NCT00603304Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of saw palmetto fruit extract in benign prostatic hyperplasia (BPH), sponsored by University of Alabama at Birmingham. Started Feb 2008; status: completed.
02
Drugs
saw palmetto fruit extract
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00603304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603304.